YIA5 PKCδ deficiency accelerates neointimal lesions in a mouse model of vascular injury involving delayed re-endothelialisation and vasohibin-1 accumulation

Xue Bai; Margariti, Andriana; Lingfang Zeng; Yanhua Hu; Qingbo Xu
September 2010
Heart;Sep2010, Vol. 96 Issue 17, pe10
Academic Journal
Objective Protein kinase C (PKC) δ functions as a signal transducer mediating several essential functions of cell proliferation and apoptosis. However, the effect of PKCδ on neointimal formation is currently unknown. In this study, we used a vascular injury model in PKCδ knockout mice to investigate the role of PKCδ in the lesion development and underlying mechanism. Methods and results 3 weeks after wire injury of femoral arteries, neointimal lesions were significantly increased in PKCδ-/- mice compared with wild-type animals. Immunohistochemical staining revealed that total numbers of smooth muscle cells and macrophages in the lesions were markedly elevated without the alterations of the ratio between these two types of cells. To further study the mechanisms of PKCδ-mediated increase in the lesion, an in vivo endothelial migration model was established to evaluate endothelial wound healing after wire injury. Data indicate that re-endothelialisation of the injured vessel was markedly delayed in PKCδ-/- mice that coincided with more severe intimal hyperplasia. When endothelial cells were cultivated from cardiac tissues of PKCδ-/- and PKCδ+/+ mice, the ability of cell migration was significantly reduced in PKCδ-/- mice, but no difference in proliferation and apoptosis was found. This altered endothelial migration was also verified by PKCδ inhibitor and siRNA techniques in wild-type cells. Interestingly, vasohibin-1, an anti-migration protein, was elevated in endothelial cells derived from PKCδ-deficient mice, which was identified largely owing to delayed protein degradation mediated by PKCδ. Downregulation of vasohibin-1 restored the migration rate of PKCδ-/- endothelial cells to a level similar to that in wild-type cells. Conclusion Our data provide the first evidence that PKCδ-enhanced neointima formation occurs mainly due to delayed re-endothelialisation, which is mediated by increased cellular vasohibin-1 that is regulated by PKCδ.


Related Articles

  • Smooth muscle cell-specific Hif-1α deficiency suppresses angiotensin II-induced vascular remodelling in mice. Imanishi, Masaki; Tomita, Shuhei; Ishizawa, Keisuke; Kihira, Yoshitaka; Ueno, Masaki; Izawa-Ishizawa, Yuki; Ikeda, Yasumasa; Yamano, Noriko; Tsuchiya, Koichiro; Tamaki, Toshiaki // Cardiovascular Research;Jun2014, Vol. 102 Issue 3, p460 

    Aim Vascular remodelling is mediated by vascular smooth muscle cell (VSMC) proliferation and hypertrophy, both processes of which are linked to medial thickening and fibrosis. Here, we show that hypoxia-inducible factor-1α (Hif-1α) expressed in smooth muscle cells (SMCs) is involved in...

  • HEXIM1 controls satellite cell expansion after injury to regulate skeletal muscle regeneration. Peng Hong; Kang Chen; Bihui Huang; Min Liu; Miao Cui; Rozenberg, Inna; Chaqour, Brahim; Pan, Xiaoyue; Barton, Elisabeth R.; Xian-Cheng Jiang; Siddiqui, M. A. Q. // Journal of Clinical Investigation;Nov2012, Vol. 122 Issue 11, p3873 

    The native capacity of adult skeletal muscles to regenerate is vital to the recovery from physical injuries and dystrophic diseases. Currently, the development of therapeutic interventions has been hindered by the com-plex regulatory network underlying the process of muscle regeneration. Using a...

  • Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway. Liu, Yu-min; Wang, Xiong; Nawaz, Ahmed; Kong, Zhao-hong; Hong, Yan; Wang, Chang-hua; Zhang, Jun-jian // Acta Pharmacologica Sinica;Dec2011, Vol. 32 Issue 12, p1475 

    Aim:To investigate the effects of wogonin (5,7-dihydroxy-8-methoxyflavone) extracted from Scutellaria baicalensis Georgi (S baicalensis) on lipotoxicity-induced apoptosis of vascular smooth muscle cells (VSMCs) and the underlying mechanisms.Methods:Cultured VSMCs were used. Apoptosis of VSMCs...

  • Rottlerin, a PKC-delta Inhibitor, Strongly Suppresses Cell Cycle Progression in Vascular Smooth Muscle Cell Through AMPK Activation. Motoshima, Hiroyuki; Kojima, Kanou; Igata, Motoyuki; Tsutsumi, Atsuyuki; Kondo, Tatsuya; Matsumura, Takeshi; Furukawa, Noboru; Tsuruzoe, Kaku; Nishikawa, Takeshi; Araki, Eiichi // Diabetes;Jun2007 Supplement 1, Vol. 56, pA599 

    Vascular smooth muscle cell (VSMC) proliferation is a critical event in the development and progression of atherosclerosis. Since protein kinase C (PKC) activation has been proposed to be involved in atherosclerosis as well as diabetic vascular complications, reagents, which can inhibit both PKC...

  • Simultaneous Increases in Proliferation and Apoptosis of Vascular Smooth Muscle Cells Accelerate Diabetic Mouse Venous Atherosclerosis. Ping, Suning; Li, Yuhuang; Liu, Shuying; Zhang, Zhengyu; Wang, Jingjing; Zhou, Yuhuan; Liu, Kefeng; Huang, Jintao; Chen, Dadi; Wang, Junmei; Li, Chaohong // PLoS ONE;10/21/2015, Vol. 10 Issue 10, p1 

    Aims: This study was designed to demonstrate simultaneous increases in proliferation and apoptosis of vascular smooth muscle cells (VSMCs) leading to accelerated vein graft remodeling and to explore the underlying mechanisms. Methods: Vein grafts were performed in non-diabetic and diabetic...

  • Mebendazole Reduces Vascular Smooth Muscle Cell Proliferation and Neointimal Formation Following Vascular Injury in Mice. Wang, Jintao; Wang, Hui; Guo, Chiao; Luo, Wei; Lawler, Alyssa; Reddy, Aswin; Wang, Julia; Sun, Eddy B.; Eitzman, Daniel T. // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Mebendazole is an antihelminthic drug that exerts its effects via interference with microtubule function in parasites. To determine the utility of mebendazole as a potential treatment for vascular diseases involving proliferation of vascular smooth muscle cells, the effects of mebendazole on...

  • Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells. Growcott, Ellena J.; Spink, Karen G.; Xiaohui Ren; Afzal, Saliha; Banner, Kathy H.; Wharton, John // Respiratory Research;2006, Vol. 7, p9 

    Background: Pulmonary arterial hypertension is a proliferative vascular disease, characterized by aberrant regulation of smooth muscle cell proliferation and apoptosis in distal pulmonary arteries. Prostacyclin (PGI2) analogues have anti-proliferative effects on distal human pulmonary artery...

  • Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation. Daniel, Jan-Marcus; Dutzmann, Jochen; Bielenberg, Wiebke; Widmer-Teske, Rebecca; Gündüz, Dursun; Hamm, Christian; Sedding, Daniel // Basic Research in Cardiology;May2012, Vol. 107 Issue 3, p1 

    Dedifferentiation, migration, and proliferation of resident vascular smooth muscle cells (SMCs) are key components of neointima formation after vascular injury. Activation of signal transducer and activator of transcription-3 (STAT3) is suggested to be critically involved in this process, but...

  • Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway. Mishra, Sudha; Vinayak, Manjula // Molecular Biology Reports;Feb2013, Vol. 40 Issue 2, p1417 

    Protein Kinase C (PKC) isozymes are key components involved in cell proliferation and their over activation leads to abnormal tumor growth. PKC follows signalling pathway by activation of downstream gene NF- kB and early transcription factor c-Myc. Over activation of NF- kB and c-Myc gene are...


Read the Article


Sign out of this library

Other Topics